A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...

In the lab, Johns Hopkins University neuroscientist Minhyeok Chang and colleagues identified tiny tubular bridges in the ...

Johns Hopkins scientists uncovered microscopic “nanotube” channels that neurons use to transfer toxic molecules. While this ...

In a study published in Neuron, a research team at the Department of Neurology at Massachusetts General Hospital, aimed to ...

Scientists are unraveling the molecular mechanisms of Alzheimer’s to develop earlier diagnoses and breakthrough therapies ...

Openwater has developed a low-intensity focused ultrasound device that might one day noninvasively disrupt microclots in long ...

Scientists have repaired a natural gateway into the brains of mice, allowing the clumps and tangles associated with Alzheimer ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

Discover how donanemab’s impact on posttreatment amyloid levels may transform Alzheimer’s treatment. Keep reading to learn ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its ...